InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporationverified

NVIVQ

Price:

$0.37

Market Cap:

$995.92K

InVivo Therapeutics Holdings Corp. is a U.S.-based biotechnology and biomaterials company, engaged in both research and clinical development. The company's primary focus is on pioneering and commercializing biopolymer scaffolding devices specifically designed for the treatment of spinal cord injuries (SCI). Its flagship product under development is the Neuro-Spinal Scaffold implant, which is constructed from a blend of biocompatible and bioresorbable polymers. These polymers include Poly lactic-co-glycolic acid (PLGA), a material frequently found in dissolvable sutures that provides crucial biocompatible support for the scaffold, and Poly-L-Lysine, a positively charged polymer used to encour...[Read more]

Industry

Biotechnology

IPO Date

2010-11-15

Stock Exchange

OTC

Ticker

NVIVQ

The ROE as of June 2026 (TTM) for InVivo Therapeutics Holdings Corporation (NVIVQ) is -60.12%

According to InVivo Therapeutics Holdings Corporation’s latest financial reports and current stock price. The company's current ROE is -60.12%. This represents a change of 203.37% compared to the average of -19.82% of the last 4 quarters.

InVivo Therapeutics Holdings Corporation (NVIVQ) Historical ROE (quarterly & annually)

How has NVIVQ ROE performed in the past?

The mean historical ROE of InVivo Therapeutics Holdings Corporation over the last ten years is -182.57%. The current -60.12% ROE has changed -67.07% with respect to the historical average. Over the past ten years (40 quarters), NVIVQ's ROE was at its highest in in the June 2018 quarter at 677.79%. The ROE was at its lowest in in the March 2015 quarter at -154.29%.

Quarterly (TTM)
Annual

Average

-182.57%

Median

-208.03%

Minimum

-310.00%

Maximum

-47.20%

InVivo Therapeutics Holdings Corporation (NVIVQ) ROE by Quarter and Year

Discovering the peaks and valleys of InVivo Therapeutics Holdings Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 226.74%

Maximum Annual ROE = -47.20%

Minimum Annual Increase = -78.48%

Minimum Annual ROE = -310.00%

Quarterly (TTM)
Annual
YearROEChange
2022-64.64%18.38%
2021-54.61%15.70%
2020-47.20%-78.48%
2019-219.27%-23.61%
2018-287.03%8.50%
2017-264.54%226.74%
2016-80.96%-58.86%
2015-196.79%-36.52%
2014-310.00%3.10%
2013-300.67%48.95%

InVivo Therapeutics Holdings Corporation (NVIVQ) Average ROE

How has NVIVQ ROE performed in the past?

The current ROE of InVivo Therapeutics Holdings Corporation (NVIVQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-55.48%

5-year avg

-134.55%

10-year avg

-182.57%

InVivo Therapeutics Holdings Corporation (NVIVQ) ROE vs. Peers

How is NVIVQ’s ROE compared to its peers?

InVivo Therapeutics Holdings Corporation’s ROE is less than RegenETP, Inc. (0%), less than Suvanza Pharma, LLC (0%), less than Novation Companies, Inc. (11.97%), less than Entourage Health Corp. (37.15%), greater than Asep Medical Holdings Inc (-58.60%), less than Point of Care Nano-Technology, Inc. (155.22%), less than Digipath, Inc. (0%), less than Nutroganics, Inc. (96.46%), less than Evolva Holding S.A. (300.91%), greater than null (-10.72%),

Build a custom stock screener for InVivo Therapeutics Holdings Corporation (NVIVQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InVivo Therapeutics Holdings Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InVivo Therapeutics Holdings Corporation (NVIVQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InVivo Therapeutics Holdings Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is InVivo Therapeutics Holdings Corporation's ROE?

How is the ROE calculated for InVivo Therapeutics Holdings Corporation (NVIVQ)?

What is the highest ROE for InVivo Therapeutics Holdings Corporation (NVIVQ)?

What is the 3-year average ROE for InVivo Therapeutics Holdings Corporation (NVIVQ)?

What is the 5-year average ROE for InVivo Therapeutics Holdings Corporation (NVIVQ)?

How does the current ROE for InVivo Therapeutics Holdings Corporation (NVIVQ) compare to its historical average?